home / stock / qgen / qgen news


QGEN News and Press, Qiagen N.V. From 01/13/26

Stock Information

Company Name: Qiagen N.V.
Stock Symbol: QGEN
Market: NYSE
Website: qiagen.com

Menu

QGEN QGEN Quote QGEN Short QGEN News QGEN Articles QGEN Message Board
Get QGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

QGEN - Qiagen N.V. (QGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13 09:26:00 ET Qiagen N.V. (QGEN) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

QGEN - QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in 2028 QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its 2026 priorities across its fi...

QGEN - Federal appeals court rejects NIH research funding cuts

2026-01-06 07:16:59 ET More on Thermo Fisher Scientific, Danaher, etc. Thermo Fisher: Refinding Some Momentum Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference...

QGEN - CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)

2025-12-22 10:15:04 ET Thesis Update About a year ago, my first analysis of CareDx, Inc. ( CDNA ) was published. Against the grain of public opinion – almost every other analysis had a Hold or Buy rating – I rating it a “Sell,” due to several ...

QGEN - QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million

Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026 Capital return to be conducted through synthetic share repurchase – combines a fast direct capital repayment to shareholders with a reverse stock split...

QGEN - Overweight Recommendation Issued On QGEN By Barclays

2025-12-15 06:15:15 ET Barclays analyst issues OVERWEIGHT recommendation for QGEN on December 15, 2025 10:56AM ET. The previous analyst recommendation was Overweight. QGEN was trading at $45.255 at issue of the analyst recommendation. The overall analyst consensus : HOLD...

QGEN - Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript

2025-12-03 18:33:27 ET Qiagen N.V. (QGEN) Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript

QGEN - Qiagen N.V. (QGEN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

2025-12-02 14:53:26 ET Qiagen N.V. (QGEN) Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

QGEN - Qiagen N.V. (QGEN) Deep Dive Into Sample Technologies: Leadership, Innovation and Future Expansion Transcript

2025-11-21 13:33:31 ET Qiagen N.V. (QGEN) Deep Dive Into Sample Technologies: Leadership, Innovation and Future Expansion November 21, 2025 9:00 AM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Deep Dive Into Sample Technologies: L...

QGEN - Qiagen N.V. (QGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript

2025-11-19 12:23:26 ET Qiagen N.V. (QGEN) Jefferies London Healthcare Conference 2025 November 19, 2025 5:30 AM EST... Read the full article on Seeking Alpha For further details see: Qiagen N.V. (QGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript

Previous 10 Next 10